CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 3. TIAM1 is cleaved by a caspase-3 family caspase in vitro. TIAM1 C1199 was in vitro transcribed and translated in the presence of [35S]methionine. The in vitro translated product was either left untreated (-) or incubated with extracts prepared from control Jurkat cells (0) or cells that had been stimulated with anti-Fas for 2 h (2). Extracts were prepared from wild-type Jurkat cells (WT) or I2.1, a Jurkat clone that is deficient in Fas-associated death domain. DEVD-CHO (100 nM) was added where indicated. Poly(ADP-ribose) polymerase, a defined caspase substrate, was used as a positive control. Reactions were resolved by SDS-PAGE and visualized by autoradiography. Arrow, TIAM1 cleavage peptide produced in vitro.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation